CD274 and neoplasm: However, ICD inducers tend to simultaneously up-regulate the expression of PD-L1 in tumor cells and thus inactivate T cells through the PD-1/PD-L1 pathway, which requires them to be used in combination with PD-1/PD-L1 blockade.